The present and future of pharmacotherapy of Alzheimer's disease: A comprehensive review

A Anand, AA Patience, N Sharma, N Khurana - European journal of …, 2017 - Elsevier
Alzheimer's disease (AD) is a generalized term used for the loss in memory and other
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …

Drug candidates in clinical trials for Alzheimer's disease

SY Hung, WM Fu - Journal of biomedical science, 2017 - Springer
Alzheimer's disease (AD) is a major form of senile dementia, characterized by progressive
memory and neuronal loss combined with cognitive impairment. AD is the most common …

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer's Disease: Preclinical to Clinical Trial Insights

K Nagori, KT Nakhate, K Yadav, Ajazuddin… - Future …, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative
disease characterized by memory loss, personality changes, and cognitive impairment. It …

Can herbs provide a new generation of drugs for treating Alzheimer's disease?

TS Anekonda, PH Reddy - Brain research reviews, 2005 - Elsevier
The overall aim of this review is to discuss cellular mechanisms at work in the progression of
AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of …

[PDF][PDF] Pathophysiology and management of Alzheimer's disease: An overview

AK Thakur, P Kamboj, K Goswami, K Ahuja - J anal pharm Res, 2018 - researchgate.net
Alzheimer's disease (AD) is the sixth-leading reason of fatality and is 70% present in all
cases of dementia. The global burden of AD is expected to accelerate from 26.6 million …

Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

S Thakral, A Yadav, V Singh, M Kumar, P Kumar… - Ageing Research …, 2023 - Elsevier
Abstract Alzheimer's disease (AD), also called senile dementia, is the most common
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …

Disease-modifying drugs in Alzheimer's disease

L Ghezzi, E Scarpini, D Galimberti - Drug design, development and …, 2013 - Taylor & Francis
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most
common cause of dementia. The early stages of AD are characterized by short-term memory …

[HTML][HTML] An update on the novel and approved drugs for Alzheimer disease

HA Alhazmi, M Albratty - Saudi Pharmaceutical Journal, 2022 - Elsevier
Introduction Given the severity of the condition and the increasing number of patients,
developing effective therapies for Alzheimer's disease has become a significant necessity …

New treatment strategies for Alzheimer's disease: is there a hope?

I Aprahamian, F Stella, OV Forlenza - Indian Journal of Medical …, 2013 - journals.lww.com
Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease, and
corresponds to the most common cause of dementia worldwide. Although not fully …

[PDF][PDF] An update on drug treatment options of Alzheimer's disease

M Allgaier, C Allgaier - Front Biosci (Landmark Ed), 2014 - academia.edu
Introduction 3. Mechanisms underlying dementia of the Alzheimer type 4. Drugs approved
for the treatment of Alzheimer's disease 4.1. Acetylcholine esterase inhibitors 4.1. 1 …